NDC 68788-8563-01 - Gabapentin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68788-8563
- Requested NDC
- 68788-8563-01
- Package NDCs from labels
- 68788-8563-3, 68788-8563-6, 68788-8563-9, 68788-8563-1, 68788-8563-8, 68788-8563-01
- Manufacturer
- Preferred Pharmaceuticals Inc.
- Effective date
- 2026-04-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Gabapentin - Preferred Pharmaceuticals Inc. | Preferred Pharmaceuticals Inc. | 2026-04-29 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68788-8563-1 | Gabapentin | 100 in 1 BOTTLE, PLASTIC | CAPSULE | 100 | 3 | |
| 68788-8563-3 | Gabapentin | 30 in 1 BOTTLE, PLASTIC | CAPSULE | 30 | 3 | |
| 68788-8563-6 | Gabapentin | 60 in 1 BOTTLE, PLASTIC | CAPSULE | 60 | 3 | |
| 68788-8563-8 | Gabapentin | 120 in 1 BOTTLE, PLASTIC | CAPSULE | 120 | 3 | |
| 68788-8563-9 | Gabapentin | 90 in 1 BOTTLE, PLASTIC | CAPSULE | 90 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68788-8563 | GABAPENTIN CAPSULE [PREFERRED PHARMACEUTICALS INC.] | 1 | Current NDC, 5 package rows | 20240206_2625c0ef-5295-41de-9e81-88001a6cbecc.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68788-8563-1 | EA - Each | 68788-8563 | 2d1f267e-3ef0-40a5-909c-b3d4c50e2862 | 1 | 2024-05-16 |
| 68788-8563-3 | EA - Each | 68788-8563 | b1437b10-b861-44f9-978a-5bc2b13193f3 | 1 | 2024-05-16 |
| 68788-8563-6 | EA - Each | 68788-8563 | 202d078f-b330-4a18-a7dd-a3b5820525eb | 1 | 2024-05-16 |
| 68788-8563-8 | EA - Each | 68788-8563 | 90fccd51-866b-40bb-bb13-63eabd8c8072 | 1 | 2024-05-16 |
| 68788-8563-9 | EA - Each | 68788-8563 | 47068409-e4a7-4d55-bb57-f3418778c8ca | 1 | 2024-05-16 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gabapentin | GABAPENTIN | Amneal Pharmaceuticals of New York LLC | b11dbff5-ceee-4a63-a093-f6efebdc2f6f | 2021-02-03 | Warnings, Adverse reactions | 310430 310432 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Proficient Rx LP | f6baeb5c-ca9c-4730-aeb8-8f8732e8ca3a | 2021-01-01 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Proficient Rx LP | c79d94ec-117d-4fb6-845d-1954e3472bb0 | 2021-01-01 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gaba 300-EZS | GABAPENTIN | PureTek Corporation | bb29692e-1546-4d05-a46a-93baf4172c7d | 2020-11-16 | Warnings, Adverse reactions | 310431 |
| Gabapentin | GABAPENTIN | Aphena Pharma Solutions - Tennessee, LLC | 3b4395f2-9440-4b67-97cc-5d16f3bdd05e | 2020-08-14 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Aphena Pharma Solutions - Tennessee, LLC | 39149f0e-30ed-4671-8be7-2a484f65d63b | 2020-08-05 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Proficient Rx LP | ded42b88-94dd-462d-bcdf-7fd34d1e49c3 | 2020-07-01 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Asclemed USA, Inc. | 45039bba-7a96-450c-95be-83a3aa4fcbd2 | 2020-06-10 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Proficient Rx LP | 8b2f38ef-0a0c-45cc-88ca-cc086bf80641 | 2020-06-01 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Aphena Pharma Solutions - Tennessee, LLC | ba2a8352-5776-4edb-914e-ce1d18ccda32 | 2020-05-27 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Proficient Rx LP | c09c66fd-cb31-41dd-b00b-acc58bd809f7 | 2020-01-01 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Proficient Rx LP | 7d77dae0-df76-4b7b-9690-713e9a60e3cd | 2019-12-01 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Proficient Rx LP | 4bae5032-f634-4d1e-b672-8a7e2bd6a5fa | 2019-11-01 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Proficient Rx LP | 92c4d589-533b-4fe4-833f-dd68cc1f7e66 | 2019-11-01 | Warnings, Adverse reactions | 310432 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Proficient Rx LP | 2ef99c3d-866a-438b-a340-8beba8d4c457 | 2019-11-01 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Cool Vanilla | OCTINOXATE, TITANIUM DIOIXIDE, OCTISALATE | BCM Cosmetique SAS | d701c221-9f68-47ff-b766-2f4f1998649f | 2019-10-08 | Warnings | 15FIX9V2JP |
| No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Amber | OCTINOXATE, TITANIUM DIOIXIDE, OCTISALATE | BCM Cosmetique SAS | 7f5e6872-4d26-410e-8afe-16a016f9a399 | 2019-10-08 | Warnings | 15FIX9V2JP |
| No7 Perfect and Perfect Advanced All in One Foundation SPF 50 Warm Ivory | OCTINOXATE, TITANIUM DIOIXIDE, OCTISALATE | BCM Cosmetique SAS | 1124ba7d-a328-409b-8c88-e74bb3e501f5 | 2019-10-08 | Warnings | 15FIX9V2JP |
| No7 Perfect and Perfect Advanced All in One Foundation SPF 50 Honey | OCTINOXATE, TITANIUM DIOIXIDE, OCTISALATE | BCM Cosmetique SAS | 9c407dc7-fcde-4660-9a06-57bd8a6b867d | 2019-10-08 | Warnings | 15FIX9V2JP |
| No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Chestnut | OCTINOXATE, TITANIUM DIOIXIDE, OCTISALATE | BCM Cosmetique SAS | f07e8bb2-30ae-4337-ad60-84f55f2ff354 | 2019-10-08 | Warnings | 15FIX9V2JP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.